Nefopam and ketamine comparably enhance postoperative analgesia

被引:79
作者
Kapfer, B
Alfonsi, P
Guignard, B
Sessler, DI
Chauvin, M [1 ]
机构
[1] Assistance Publ Hop Paris, Hop Ambroise Pare, Dept Anesthesia, F-92100 Boulogne, France
[2] Assistance Publ Hop Paris, Hop Ambroise Pare, INSERM E 332, F-92100 Boulogne, France
[3] Univ Louisville, Outcomes Res Inst, Louisville, KY USA
[4] Univ Louisville, Dept Anesthesiol, Louisville, KY USA
[5] Univ Louisville, Dept Pharmacol, Louisville, KY USA
关键词
D O I
10.1213/01.ANE.0000138037.19757.ED
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Opioids alone sometimes provide insufficient postoperative analgesia. Coadministration of drugs may reduce opioid use and improve opioid efficacy. We therefore tested the hypothesis that the administration of ketamine or nefopam to postoperative patients with pain only partly alleviated by morphine reduces the amount of subsequent opioid necessary to produce adequate analgesia. Patients (n = 77) recovering from major surgery were given up to 9 mg of IV morphine. Those who still had pain were randomly assigned to blinded administration of 1) isotonic saline (control group; n = 21),2) ketamine 10 mg (ketamine group; n = 22), or 3) nefopam 20 mg (nefopam group; n = 22). Three-milligram morphine boluses were subsequently given at 5-min intervals until adequate analgesia was obtained, until 60 min elapsed after the beginning of study drug administration, or until ventilation became insufficient (respiratory rate <10 breaths/min or saturation by pulse oximetry <95%). Supplemental morphine (i.e., after test drug administration) requirements were significantly more in the control group (mean SD; 17 +/- 10 mg) than in the nefopam (10 +/- 5 mg; P < 0.005) or ketamine (9 +/- 5 mg; P < 0.001) groups. Morphine titration was successful in all ketamine and nefopam patients but failed in four control patients (two because of respiratory toxicity and two because of persistent pain). Tachycardia and profuse sweating were more frequent in patients given nefopam, and sedation was more intense with ketamine; however, the incidence of other potential complications did not differ among groups.
引用
收藏
页码:169 / 174
页数:6
相关论文
共 32 条
[1]   Synergistic antinociceptive effects of ketamine and morphine in the orofacial capsaicin test in the rat [J].
Alvarez, P ;
Saavedra, G ;
Hernández, A ;
Paeile, C ;
Pelissier, T .
ANESTHESIOLOGY, 2003, 99 (04) :969-975
[2]   Short-term infusion of the μ-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal [J].
Angst, MS ;
Koppert, W ;
Pahl, I ;
Clark, DJ ;
Schmelz, M .
PAIN, 2003, 106 (1-2) :49-57
[3]   Adjunctive analgesia with intravenous propacetamol does not reduce morphine-related adverse effects [J].
Aubrun, F ;
Kalfon, F ;
Mottet, P ;
Bellanger, A ;
Langeron, O ;
Coriat, P ;
Riou, B .
BRITISH JOURNAL OF ANAESTHESIA, 2003, 90 (03) :314-319
[4]   Relationships between measurement of pain using visual analog score and morphine requirements during postoperative intravenous morphine titration [J].
Aubrun, F ;
Langeron, O ;
Quesnel, C ;
Coriat, P ;
Riou, B .
ANESTHESIOLOGY, 2003, 98 (06) :1415-1421
[5]   Neuronal sensitization and its behavioral correlates in a rat model of neuropathy are prevented by a cyclic analog of orphenadrine [J].
Biella, GEM ;
Groppetti, A ;
Novelli, A ;
Fernández-Sánchez, MT ;
Manfredi, B ;
Sotgiu, ML .
JOURNAL OF NEUROTRAUMA, 2003, 20 (06) :593-601
[6]   Interaction of a combination of morphine and ketamine on the nociceptive flexion reflex in human volunteers [J].
Bossard, AE ;
Guirimand, F ;
Fletcher, D ;
Gaude-Joindreau, V ;
Chauvin, M ;
Bouhassira, D .
PAIN, 2002, 98 (1-2) :47-57
[7]   EVIDENCE OF THE INVOLVEMENT OF DOPAMINE IN THE ANALGESIC EFFECT OF NEFOPAM [J].
ESPOSITO, E ;
ROMANDINI, S ;
MERLOPICH, E ;
MENNINI, T ;
SAMANIN, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1986, 128 (03) :157-164
[8]   ANTINOCICEPTIVE EFFECTS OF (+/-)-NEFOPAM, (+)-NEFOPAM AND (-)-NEFOPAM IN MICE [J].
FASMER, OB ;
BERGE, OG ;
JORGENSEN, HA ;
HOLE, K .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1987, 39 (07) :508-511
[9]   Nefopam, an analogue of orphenadrine, protects against both NMDA receptor-dependent and independent veratridine-induced neurotoxicity [J].
Fernández-Sánchez, MT ;
Díaz-Trelles, R ;
Groppetti, A ;
Manfredi, B ;
Brini, AT ;
Biella, G ;
Sotgiu, ML ;
Novelli, A .
AMINO ACIDS, 2002, 23 (1-3) :31-36
[10]   EVALUATION OF NEFOPAM AS A MONOAMINE UPTAKE INHIBITOR IN-VIVO IN MICE [J].
FULLER, RW ;
SNODDY, HD .
NEUROPHARMACOLOGY, 1993, 32 (10) :995-999